Delivery Order SPE2DB22D1202-SPE2DB24FVMV4
Award Date
9/5/24
Potential Completion Date
9/6/24
Potential Value
$33K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor, to provide AIMOVIG 140 mg/mL autoinjectors. The $1,357.86 firm-fixed-price contract has a completion date of July 10, 2024. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to deliver a broad range of pharmaceutical products and medical supplies to DLA...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,357.86 to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is for the provision of the prescription medication Aimovig 140 mg/ml autoinjector, with a completion date of July 3, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which allows the...
The U.S. government, through the Defense Logistics Agency (DLA) Troop Support Medical, awarded a $3,134.10 Firm Fixed Price Delivery Order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at up to $999,999,999.00 through December 31, 2025, which enables the DLA to efficiently procure a comprehensive range of...
The U.S. Department of Defense, through the Defense Logistics Agency (DLA), awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $2,683.28 firm fixed price delivery order contract to provide AIMOVIG 70 MG/ML AUTOINJECTORML, a pharmaceutical product, to support military treatment programs and facilities. This award is part of an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded solely to Amerisourcebergen Drug Corp, which...
The U.S. Defense Logistics Agency (DLA) awarded a $8,465.56 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract has a ceiling value of $8,465.56 and an ultimate completion date of September 26, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical medical supplies to support military treatment facilities and healthcare programs. This award is part of a...
The Defense Logistics Agency (DLA) awarded a $3,125.09 firm-fixed price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of AIMOVIG 140 MG/ML autoinjectors. The order has an ultimate completion date of August 23, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, for providing a comprehensive range of medical commodities to support military treatment programs and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Aimovig 140 mg/ml autoinjectors. The $1,810.48 firm-fixed-price contract has a period of performance through November 4, 2024 and does not utilize any set-aside requirements. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a...
The U.S. Defense Logistics Agency (DLA) awarded a $4,526.20 firm-fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of AIMOVIG 140 MG/ML autoinjectors. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation....
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $10,901.62 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML. This order is part of a larger Indefinite Delivery Contract (IDC) with a ceiling value of up to $999,999,999.00, awarded to Amerisourcebergen by the DLA to provide a comprehensive range of pharmaceutical products and medical supplies to DLA...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order worth $10,844.44 for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 3, 2025. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...